Moderna director granted 12,908 stock options
Moderna, Inc. director Noubar Afeyan received a grant of stock options covering 12,908 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Moderna, Inc. director Noubar Afeyan received a grant of stock options covering 12,908 shares of common stock. The options have an exercise price of $48.79 per share and expire on May 6, 2036.
According to the terms, this option will become fully vested and exercisable on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, subject to his continued service. Following this grant, Afeyan holds 12,908 stock options directly in this award.
Insider Trade Summary
Grant/Award: 12,908 shares
Grant/Award
1 txn
Insider
AFEYAN NOUBAR
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 12,908 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 12,908 contracts (Direct)
Footnotes (1)
- F1. This option will become fully vested and exercisable on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.
Key Figures
Options granted: 12,908 options
Exercise price: $48.79 per share
Underlying shares: 12,908 shares
+2 more
5 metrics
Options granted
12,908 options
Stock option grant to director Noubar Afeyan
Exercise price
$48.79 per share
Strike price for newly granted stock options
Underlying shares
12,908 shares
Common stock underlying the option award
Expiration date
May 6, 2036
Option term end for this grant
Post‑grant options held
12,908 options
Total options from this award following the transaction
Key Terms
Stock Option, exercise price, derivative, Annual Meeting of Shareholders, +1 more
5 terms
Stock Option financial
"Stock Option (Right to Buy)"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price: "48.7900""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
derivative financial
"transaction_type: "derivative""
A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.
vesting financial
"This option will become fully vested and exercisable on the earlier of May 6, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Moderna (MRNA) director Noubar Afeyan report in this Form 4?
Noubar Afeyan reported receiving a grant of stock options for 12,908 shares of Moderna common stock. These options were awarded at an exercise price of $48.79 per share and represent compensation rather than an open-market stock purchase or sale.
How many Moderna (MRNA) stock options were granted to Noubar Afeyan?
Noubar Afeyan was granted stock options on 12,908 underlying shares of Moderna common stock. This entire option grant is recorded as a single derivative transaction and is held directly, according to the ownership details in the filing.
What is the exercise price of Noubar Afeyan’s new Moderna (MRNA) stock options?
The exercise price of Noubar Afeyan’s newly granted Moderna stock options is $48.79 per share. This is the price he would pay per share to convert the options into Moderna common stock once the options are vested and exercisable.
When do Noubar Afeyan’s Moderna (MRNA) stock options vest and become exercisable?
The stock options will fully vest and become exercisable on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders. Vesting is conditioned on Afeyan’s continued service with the company through the applicable vesting date.
When do the newly granted Moderna (MRNA) stock options to Noubar Afeyan expire?
Noubar Afeyan’s newly granted Moderna stock options expire on May 6, 2036. After that expiration date, any unexercised portion of this 12,908-share option award would no longer be exercisable or provide rights to purchase Moderna common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
